☆ 4.6 Review

A Greater Increase in Complement C5a Receptor 1 Level at Onset and a Smaller Decrease in Immunoglobulin G Level after Recovery in Severer Coronavirus Disease 2019 Patients: A New Analysis of Existing Data with a New Two-Tailed t-Test

BIOLOGY-BASEL (2023)

Related references

Note: Only part of the references are listed.

Review Medicine, General & Internal

COVID-19 associated coagulopathy: Mechanisms and host-directed treatment

Jiri Plasek et al.

Summary: COVID-19 is associated with specific coagulopathy that can result in thrombotic complications and organ damage. The coagulopathy exhibits features of thrombotic microangiopathy and complement-mediated hemolytic-uremic syndrome. Diagnosis of COVID-19-associated coagulopathy is based on elevated fibrinogen, D-dimers, von Willebrand factor, dysregulated complement, and increased cytokine levels. Treatment options include anticoagulation and host-directed therapeutic pathways.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2022)

Add to Collection

Article Medicine, Research & Experimental

The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19

Alexander P. J. Vlaar et al.

Summary: This study reports the pharmacokinetic/pharmacodynamic (PK/PD) analysis of using the monoclonal antibody vilobelimab (IFX-1) to selectively block C5a in patients with severe COVID-19. The results demonstrate that vilobelimab efficiently inhibits C5a and has a favorable safety profile.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)

Add to Collection

Review Hematology

Tissue factor in COVID-19-associated coagulopathy

Saravanan Subramaniam et al.

Summary: Micro-and macro-thrombi in arteries and veins of critically ill COVID-19 patients highlight the occurrence of COVID-19-associated coagulopathy. Tissue factor (TF) may play a significant role in COVID-19 patients, with proinflammatory cytokines possibly triggering abnormal TF expression and coagulation activation.

THROMBOSIS RESEARCH (2022)

Add to Collection

Article Critical Care Medicine

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Alexander P. J. Vlaar et al.

Summary: The study found that in addition to standard care, vilobelimab improves survival outcomes and significantly reduces mortality in COVID-19 patients on invasive mechanical ventilation. Vilobelimab could be considered as an additional therapy for patients in this setting.

LANCET RESPIRATORY MEDICINE (2022)

Add to Collection

Article Immunology

C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d

Daria Kowalska et al.

Summary: This study found that high levels of complement C5a in COVID-19 patients are associated with disease severity, but there is no clear link with markers of upstream complement activation, suggesting the existence of a non-canonical source of C5a.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19

Sokratis A. Apostolidis et al.

Summary: Patients with severe COVID-19 exhibit higher levels of platelet activation, which is associated with poor clinical outcomes and thrombotic events. Plasma from COVID-19 patients activates platelets from healthy donors and is correlated with kidney and liver injury. Blocking certain signaling pathways reverses this platelet hyperactivity.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathy

Jing Li et al.

Summary: Emerging evidence suggests a strong association between multisystem organ failure in COVID-19 patients and various coagulopathies, presenting a clinical challenge for treatment. Understanding the mechanisms of complement cascade activation in the genesis of COVID-19-associated coagulopathy could lead to the development of novel anticoagulant drugs targeting C5a/C5aRs signaling.

CYTOKINE & GROWTH FACTOR REVIEWS (2021)

Add to Collection

Article Virology

Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay

Chang Zhou et al.

Summary: An established indirect ELISA method showed good specificity and sensitivity in detecting antibodies against SARS-CoV-2. The study found that IgM and IgG antibodies appeared almost simultaneously in patients in the early stage, but the level of IgG antibodies could not maintain a high plateau within the 7-month observation period.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19

Kyoung-Ho Song et al.

Summary: The increase in post-negative positive RT-PCR results among recovered COVID-19 patients may be due to the detection of RNA particles rather than reinfection. IgG and IgM levels do not increase after this stage.

KOREAN JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Article Infectious Diseases

Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population

Carlos David Araujo Bichara et al.

Summary: This study evaluated the prevalence and persistence of anti-SARS-CoV-2 IgG antibodies in volunteers 90 days after COVID-19 diagnosis in the Brazilian Amazon. It found a high frequency of loss of IgG antibodies within 3 months, with individuals who maintained IgG showing more severe symptoms requiring longer hospital stays.

BMC INFECTIOUS DISEASES (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Previous COVID-19 Infection and Antibody Levels After Vaccination

Hamad Ali et al.

Summary: Individuals with previous COVID-19 infection showed higher and more sustained levels of SARS-CoV-2 antibodies after COVID-19 vaccination compared to those without previous infection. Vaccinated individuals without previous COVID-19 infection experienced a faster decline in IgG and neutralizing antibodies compared to those with prior infection. Efforts should be made to prioritize vaccination for more individuals, especially those without previous COVID-19 infection, due to inconsistent vaccine supply globally.

FRONTIERS IN PUBLIC HEALTH (2021)

Add to Collection

Editorial Material Medicine, General & Internal

A novel coronavirus outbreak of global health concern

Chen Wang et al.

LANCET (2020)

Add to Collection

Article Multidisciplinary Sciences

A new coronavirus associated with human respiratory disease in China

Fan Wu et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Add to Collection

Letter Biochemistry & Molecular Biology

The proximal origin of SARS-CoV-2

Kristian G. Andersen et al.

NATURE MEDICINE (2020)

Add to Collection

Article Virology

Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity

Wen-Hua Kong et al.

VIROLOGICA SINICA (2020)

Add to Collection

Article Multidisciplinary Sciences

Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis

Julien Carvelli et al.

NATURE (2020)

Add to Collection

Article Medicine, Research & Experimental

Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis

Panagiotis Skendros et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Editorial Material Immunology

The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics

Trent M. Woodruff et al.

TRENDS IN IMMUNOLOGY (2020)

Add to Collection

Article Microbiology

A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients

Yuxin Chen et al.

PLOS PATHOGENS (2020)

Add to Collection

Article Immunology

Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study

Chao Yang et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Article Immunology

Severe Acute Respiratory Syndrome Historical, Epidemiologic, and Clinical Features

David S. C. Hui et al.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2019)

Add to Collection

Article Multidisciplinary Sciences

Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression

Robert M. Paris et al.

PLOS ONE (2015)

Add to Collection

Article Computer Science, Interdisciplinary Applications

An improved approximation to the precision of fixed effects from restricted maximum likelihood

Michael G. Kenward et al.

COMPUTATIONAL STATISTICS & DATA ANALYSIS (2009)

Add to Collection

Article Public, Environmental & Occupational Health

Regression to the mean: what it is and how to deal with it

AG Barnett et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.